Hear from our CEO, Adrian Treverton, about treating non-melanoma skin cancer patients safely during COVID. Patients most likely to develop basal or squamous cell carcinoma are those in the age range at greater risk of serious illness from COVID, so safe and short treatment options are important.
Xstrahl to Showcase Dual Modality Treatment Solution for Dermatologists at NorCal 2024
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the CalDerm 2024 NorCal Conference at the Meritage Resort & Spa from May 3-5 in Napa, CA.